Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Visx' excimer laser gets approvable recommendation

This article was originally published in Clinica

Executive Summary

Visx' (US) excimer laser system for photorefractive keratectomy received a conditional approval recommendation from the US FDA's ophthalmic devices advisory panel on October 20th. Panel members criticised the company for having incomplete patient follow-up and said they would not recommend approval until two-year follow-up included 90-95% of patients. Visx is seeking marketing approval for use of the laser in patients 18 years and older with -1.0 to -6.0 dioptre myopia with a best corrected vision of at least 20/40.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093822

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel